Clinical Trial Update: Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 follow-up study (EPITOPE) assessing long-term efficacy and safety of DBV712 in young children wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• DBV712

Snippet

Sponsor: DBV Technologies | Conditions: Peanut Allergy | Phase 3 | Status: COMPLETED